scispace - formally typeset
Z

Zoltan Laszik

Researcher at University of California, San Francisco

Publications -  104
Citations -  5035

Zoltan Laszik is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Kidney & Pancreas. The author has an hindex of 28, co-authored 100 publications receiving 4503 citations. Previous affiliations of Zoltan Laszik include University of Turku & University of California.

Papers
More filters
Journal ArticleDOI

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

TL;DR: In severe meningococcal sepsis, protein C activation is impaired, a finding consistent with down-regulation of the endothelial thrombomodulin-endothelial protein C receptor pathway.
Journal ArticleDOI

The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis

TL;DR: It is concluded that protein C/activated protein C binding to EPCR contributes to the negative regulation of the coagulopathic and inflammatory response to E coli and that E PCR provides an additional critical step in the host defense against E coli.
Journal ArticleDOI

Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels Implications for the Control of the Protein C Pathway

TL;DR: EPCR may be important in enhancing protein C activation on large vessels and the presence of high levels of EPCR on arterial vessels may help explain why partial protein C deficiency is a weak risk factor for arterial thrombosis.
Journal ArticleDOI

Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc

TL;DR: Diverse neoplastic lesions, including colon cancer and melanoma-derived cells lines, expressed both Tn and STn antigen due to loss-of-function mutations in Cosmc, the first example of somatic mutations in multiple types of cancers that cause global alterations in cell surface carbohydrate antigen expression.